SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-18-000404
Filing Date
2018-07-05
Accepted
2018-07-05 11:40:51
Documents
1
Group Members
CLARUS VENTURES III GP, L.P.CLARUS VENTURES III, LLCDENNIS HENNERKURT WHEELERNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAKSCOTT REQUADT

Document Format Files

Seq Description Document Type Size
1 CLARUS LIFESCIENCES III, L.P. AVROBIO, INC. -- SCHEDULE 13D clarus3-avrobio13d_18221.htm SC 13D 297323
  Complete submission text file 0001072613-18-000404.txt   299227
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Filed by) CIK: 0001597143 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1214
Type: SC 13D

Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Subject) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90532 | Film No.: 18939916
SIC: 2836 Biological Products, (No Diagnostic Substances)